u/Prize_Mortgage_5463

If price is the reason you're looking at compounded semaglutide, line it up against the Wegovy pill first. NovoCare's self-pay pill starts cheap and climbs as the dose steps up, so the savings aren't the same every month.

Wegovy pill on NovoCare, following the label's step-up: $149 for month one (1.5 mg), $199 for month two (4 mg), then $299 a month at 9 mg and at the 25 mg maintenance dose. First 6 months: $1,544.

Compounded, month to month, providers' posted prices:

Embody and SnagRx: both currently show $69 a month under a fall sale banner. Embody says the price depends on the plan length you pick at checkout (4 to 52 weeks), and its multi-month plans are non-refundable, so check which term the $69 is attached to before paying.

HealthRX: $149 the first month on subscribe, then $165. First 6 months: $974.

Trimi: $175 a month. First 6 months: $1,050.

So in month one HealthRX matches the pill and Trimi is $26 more. By month three the pill is at $299, about $130 a month more than either one. Over six months it comes to about $490 to $570.

Prepaying lowers it more on paper (HealthRX $714, Trimi $720 for 6 months), but read the cancel terms. Trimi says ending treatment doesn't refund a prepaid term. HealthRX says it refunds unshipped doses if you cancel.

The other difference: the pill is FDA-approved, while these are compounded, so not FDA-approved. Which route fits is a conversation with your prescriber. This is only the cost side.

Source: NovoCare Wegovy self-pay offer page, Wegovy prescribing information, and Embody, SnagRx, HealthRX and Trimi pricing pages, read Oct 8, 2026. Not medical advice.

If price is the reason you're looking at compounded semaglutide, line it up against the Wegovy pill first. NovoCare's self-pay pill starts cheap and climbs as the dose steps up, so the savings aren't the same every month.

Wegovy pill on NovoCare, following the label's step-up: $149 for month one (1.5 mg), $199 for month two (4 mg), then $299 a month at 9 mg and at the 25 mg maintenance dose. First 6 months: $1,544.

Compounded, month to month, providers' posted prices:

Embody and SnagRx: both currently show $69 a month under a fall sale banner. Embody says the price depends on the plan length you pick at checkout (4 to 52 weeks), and its multi-month plans are non-refundable, so check which term the $69 is attached to before paying.

HealthRX: $149 the first month on subscribe, then $165. First 6 months: $974.

Trimi: $175 a month. First 6 months: $1,050.

So in month one HealthRX matches the pill and Trimi is $26 more. By month three the pill is at $299, about $130 a month more than either one. Over six months it comes to about $490 to $570.

Prepaying lowers it more on paper (HealthRX $714, Trimi $720 for 6 months), but read the cancel terms. Trimi says ending treatment doesn't refund a prepaid term. HealthRX says it refunds unshipped doses if you cancel.

The other difference: the pill is FDA-approved, while these are compounded, so not FDA-approved. Which route fits is a conversation with your prescriber. This is only the cost side.

Source: NovoCare Wegovy self-pay offer page, Wegovy prescribing information, and Embody, SnagRx, HealthRX and Trimi pricing pages, read Oct 8, 2026. Not medical advice.

If you're paying NovoCare cash and stuck between the shot and the pill, the gap at the top doses ($299 vs $349 a month) undersells how the first few months play out, because the two step up on different price ladders.

Following the label's dose schedule, one fill a month:

Pill: 1.5 mg $149, 4 mg $199, 9 mg $299, then 25 mg at $299. First 6 months: $1,544.

Pen, new patient: 0.25 mg and 0.5 mg at $199 each (the intro price, 2 fills), then 1 mg, 1.7 mg and 2.4 mg at $349. First 6 months: $1,794.

So about $250 apart over six months, then $50 a month after that if you'd stay on 2.4 mg, or $100 a month if your prescriber takes you to Wegovy HD 7.2 mg ($399).

The date to watch: NovoCare says the $199 pen intro runs through Dec 31, 2026. Without it the starter pens are $349 like the rest, and the six-month gap grows to $550. The page doesn't put an end date on the pill prices.

A couple of things apply to both. Self-pay doesn't count toward your insurance deductible or out-of-pocket max. And the self-pay prices are open to people on government plans too. Only the $25 savings card shuts them out. If you're on Part D, the Medicare GLP-1 Bridge ($50 a month, if you qualify) beats both.

Real life won't follow the table exactly. Plenty of people stay on a dose longer than a month, which shifts the math. Pill or shot is a call for you and your prescriber. This is only the cost side.

Source: NovoCare Wegovy self-pay offer page and the Wegovy prescribing information (dosing tables), checked Oct 5, 2026. Not medical advice.

Short version: the lowest compounded semaglutide prices are usually a one-year prepay, charged upfront and non-refundable. Prepaying only beats paying monthly if you would have stayed on it for most of the year.

Providers' posted prices, read Oct 1, 2026 (all compounded, not FDA-approved):

- Embody: $79/month month to month, or $828 upfront for one year ($69/month). Its refund policy says multi-month plans are "non-refundable in whole and in part," except if a clinician finds you medically ineligible.

- HealthRX: $149 first month, then $165; one-year prepay $1,188 ($99/month). Its pricing page says unshipped doses are refunded if you cancel.

- Trimi: $175 month to month; one-year prepay $1,188 ($99/month). Full refund before the prescription is issued, final after that.

Break-even vs. paying monthly at the same provider:

- Embody: 10 months = $790, 11 months = $869. Prepay wins only at 11+ months.

- HealthRX: 7 months = $1,139, 8 months = $1,304. Prepay wins at 8+.

- Trimi: 6 months = $1,050, 7 months = $1,225. Prepay wins at 7+.

Before paying, check:

- Is the headline price month to month or a prepaid term, and what is charged today?

- What is refundable if you stop in month two (side effects, a dose pause, new insurance)?

- Does the price change as the dose goes up?

- Is it a state-licensed pharmacy, and the base drug rather than a salt form?

For comparison, the FDA-approved Wegovy pill is $149/month at 1.5 mg on NovoCare, no prepay. FDA says it does not review compounded drugs for safety, effectiveness or quality. Dose and switching decisions belong with your prescriber.

Source: joinem.co, healthrx.com/pricing, trytrimi.com/pricing (providers' posted prices), NovoCare Wegovy offer page, FDA "Concerns with Unapproved GLP-1 Drugs," checked Oct 1, 2026. Not medical advice.

Short version: if your commercial plan covers the drug, the manufacturer card gets a fill to as little as $25, but every card has a cap. If it doesn't, official cash prices usually beat Lilly's "without coverage" card. Check next year's formulary before open enrollment closes.

Plan covers it (commercial only, government plans excluded):

- Wegovy savings card: as little as $25, max savings $100/month (NovoCare)

- Zepbound single-dose pen card: as little as $25, max $100 per 1-month fill and $1,300 per calendar year; ends Dec 31, 2026 (Lilly)

- Foundayo card: as little as $25, max $100/month and $1,000/year (Lilly)

Plan does not cover it:

- Zepbound "without coverage" card: as low as $499/month

- LillyDirect Zepbound (vial or KwikPen): $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5 mg and up with refills within 45 days (otherwise $499 at 7.5 mg, $699 at 10 mg and up)

- NovoCare Wegovy pens: $199 for 2 starter fills (new patients, through Dec 31, 2026), then $349; HD 7.2 mg $399; pills $149 to $299

- Foundayo self-pay: from $149/month

Before open enrollment (HealthCare.gov: Nov 1 to Jan 15, Dec 15 for a Jan 1 start; Medicare: Oct 15 to Dec 7):

- Search each plan's 2027 drug list, not this year's

- Ask whether weight-loss use needs prior authorization or is excluded even when the drug is listed

- On Medicare Part D: the GLP-1 Bridge is $50/month, covers the Zepbound KwikPen only (not vials), and excludes people with type 2 diabetes

Any switch for cost reasons is for you and your prescriber to decide.

Source: NovoCare, LillyDirect and Zepbound savings pages (lilly.com), Foundayo savings page, HealthCare.gov, Medicare.gov GLP-1 Bridge fact sheet, checked Sep 30, 2026. Not medical advice.